Mr. Speaker, the Conservatives are pleased to submit a dissenting report. We thank the witnesses for their work.
Our dissenting report makes a number of important points. We note, for example, that the Canadian government has primarily distributed doses of AstraZeneca that were not recommended for use in Canada. We sought to understand how the government could justify recommending against a vaccine for Canadians while distributing it to the developing world. It is not entirely surprising that this inconsistency may have contributed to vaccine hesitancy.
We also note that companies sought indemnification clauses that would protect them from being sued by people in developing countries in the event of vaccine injury. The indemnification clauses involved a no-fault mechanism that was funded by states, not by industry, and we believe that an honest reckoning with the reality of low vaccination uptake in certain quarters should have taken a serious look at some of these issues.
Again, we thank the witnesses for their important work.